TG Therapeutics, Inc.
TGTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $129 | $132 | $180 |
| Short-Term Investments | – | $123 | $144 | $131 |
| Receivables | – | $232 | $190 | $129 |
| Inventory | – | $155 | $158 | $110 |
| Other Curr. Assets | – | $25 | $20 | $16 |
| Total Curr. Assets | – | $664 | $645 | $566 |
| Property Plant & Equip (Net) | – | $7 | $7 | $7 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $0 | $0 | $0 |
| Long-Term Investments | – | $29 | $2 | $1 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | $3 | $3 | $3 |
| Total NC Assets | – | $39 | $12 | $11 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $703 | $657 | $578 |
| Liabilities | – | – | – | – |
| Payables | – | $0 | $0 | $0 |
| Short-Term Debt | – | $1 | $1 | $1 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $24 | $17 | $11 |
| Other Curr. Liab. | – | $147 | $142 | $78 |
| Total Curr. Liab. | – | $172 | $160 | $91 |
| LT Debt | – | $253 | $253 | $253 |
| Deferred Rev, NC | – | $2 | $7 | $12 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $0 | $0 | $0 |
| Total NC Liab. | – | $254 | $259 | $265 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $9 | $9 | $9 |
| Total Liabilities | – | $426 | $419 | $355 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $0 | $0 | $0 |
| Retained Earnings | – | -$1,496 | -$1,524 | -$1,529 |
| AOCI | – | $0 | $0 | $0 |
| Other Equity | – | $1,772 | $1,761 | $1,751 |
| Total Equity | – | $276 | $237 | $222 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $703 | $657 | $578 |
| Net Debt | $0 | $125 | $122 | $74 |